REAL-WORLD OUT-OF-POCKET EXPENSES (OPE) AMONG ADVANCED (STAGE IIIB/C AND IV) BREAST CANCER (ABC) PATIENTS UNDERGOING TREATMENT IN THE UNITED STATES (US)

被引：0
|
作者：
Byrne, K. S. [1 ]
Bailey, A. [1 ]
Rider, A. [1 ]
机构：
[1] Adelphi Real World, Bollington, England
来源：
VALUE IN HEALTH | 2018年 / 21卷
关键词：
D O I：
10.1016/j.jval.2018.04.155
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PCN77
引用
收藏
页码：S25 / S25
页数：1
相关论文
共 50 条
  • [31] Real-world health-related quality of life (HRQoL) among HER2-negative (HER2-) advanced breast cancer (ABC) patients in EU3 and US
    Lewis, K.
    Ndirangu, K.
    Clayton, E.
    Zhao, Q.
    Lambert, A.
    Meier, G.
    Chabot, I.
    ANNALS OF ONCOLOGY, 2021, 32 : S497 - S497
  • [32] BRCA1/2 status, treatment patterns and safety outcomes in HER2-advanced breast cancer (ABC): Results from a US real-world study
    Lux, Michael P.
    Lewis, Katie
    Rider, Alex
    Niyazov, Alexander
    CANCER RESEARCH, 2020, 80 (04)
  • [33] A multinational study of real-world treatment patterns among patients with early stage HR+/HER2-breast cancer (BC)
    Criscitiello, C.
    Spurden, D.
    Rider, A.
    Williams, R.
    Corsaro, M.
    Pike, J.
    Law, E. H.
    ANNALS OF ONCOLOGY, 2020, 31 : S42 - S43
  • [34] Real-world evidence on predictors of survival for hormone-positive and triple-negative advanced breast cancer by treatment and BRCA status in the United States.
    Zhang, Dongmu
    Raskin, Leon
    Sebby, Wendy
    He, Lei
    Pawar, Sandeep
    Narod, Steven A.
    Olopade, Olufunmilayo I.
    Liede, Alexander
    JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16) : E18754 - E18754
  • [35] REAL-WORLD TREATMENT PATTERNS OF PATIENTS WITH ADVANCED (STAGE II-IV) OVARIAN CANCER CLASSIFIED AS RESISTANT OR REFRACTORY TO FRONTLINE PLATINUM-BASED THERAPY
    Byrne, K.
    Moon, R.
    Chang, J.
    Hubanova, P.
    Doherty, J. P.
    Cappelleri, J. C.
    VALUE IN HEALTH, 2018, 21 : S70 - S71
  • [36] Real-World Treatment Patterns Among Patients with Newly Diagnosed (ND) Acute Myeloid Leukemia (AML) with TP53 Mutation in the United States (US)
    Bystrom, Rebecca
    Fernandes, Laura L.
    Wynne, Joseph
    Pulte, Dianne
    Hansen, Eric
    Belli, Andrew J.
    Barcellos, Anna
    Zettler, Christina M.
    Vallejo, Jonathon
    Norsworthy, Kelly
    De Claro, Angelo
    Lerro, Catherine
    Theoret, Marc R.
    Wang, Ching-Kun
    Rivera, Donna
    BLOOD, 2023, 142
  • [37] Assessment of side effects (SEs) impacting quality of life (QoL) in patients (pts) undergoing treatment (tx) for advanced breast cancer (ABC) in clinical practice: A real-world (RW) multi-country survey
    Cardoso, F.
    Rihani, J.
    Aubel, D.
    de Courcy, J.
    Harmer, V.
    Harbeck, N.
    Casas, A.
    Rugo, H. S.
    Fasching, P. A.
    Haftchenary, S.
    Pathak, P.
    Schumacher-Wulf, E.
    ANNALS OF ONCOLOGY, 2022, 33 : S208 - S209
  • [38] Real-world clinical outcomes in patients (pts) with HR+/HER2-metastatic breast cancer (mBC) treated with chemotherapy (CT) in the United States (US)
    Tolaney, Sara M.
    Punie, Kevin
    Kurian, Allison W.
    Ntalla, Ioanna
    Verret, Wendy
    Sadetsky, Natalia
    Sjekloca, Nikoleta
    Stokes, Michael
    Jhaveri, Komal L.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [39] Real-World Patient Characteristics, Treatment Patterns, and Outcomes for Patients With Stage III or IV Classic Hodgkin Lymphoma Treated With Frontline ABVD: A Retrospective Database Review in the United States
    Winter, Allison
    Liu, Nicholas
    Surinach, Andy
    Fanale, Michelle
    Yu, Kristina S.
    Narkhede, Mayur
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (07): : 527 - 534
  • [40] real-world treatment patterns and clinical outcomes among patients with advanced urothelial carcinoma in the United States (vol 40, pg 195.e1, 2022)
    Geynisman, Daniel M.
    Broughton, Edward
    Hao, Yi
    Zhang, Ying
    Le, Trong
    Huo, Stephen
    UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2023, 41 (05) : 259 - 259
12345